logo
Book a meeting
Vivacitas Oncology

Vivacitas Oncology

Biotechnology, 1990 N BLVD, Walnut Creek, California, 94596, United States, 1-10 Employees

vivaoncology.com

  • twitter
  • LinkedIn

Who is VIVACITAS ONCOLOGY

Vivacitas is a private clinical-stage biopharmaceutical company focused on developing next-generation oncological therapies and re-designing current treatments that, even when efficacious...

Read More

lock icon Get Full Access
map
  • 1990 N California BLVD, Walnut Creek, California, 94596, United States Headquarters: 1990 N California BLVD, Walnut Creek, California, 94596, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8011

checked-icon Does something look wrong? Fix it. | View contact records from VIVACITAS ONCOLOGY

Vivacitas Oncology Org Chart and Mapping

Employees
Scott Vandermeer

Scott Vandermeer

CEO, CFO, Co-Founder and Director

See Full Org Chart arrow
email-formate-icon
View Email Formats for Vivacitas Oncology
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Vivacitas Oncology

Answer: Vivacitas Oncology's headquarters are located at 1990 N BLVD, Walnut Creek, California, 94596, United States

Answer: Vivacitas Oncology's official website is https://vivaoncology.com

Answer: Vivacitas Oncology's revenue is Under $1 Million

Answer: Vivacitas Oncology's SIC: 8011

Answer: Vivacitas Oncology has 1-10 employees

Answer: Vivacitas Oncology is in Biotechnology

Answer: Vivacitas Oncology contact info: Phone number: Website: https://vivaoncology.com

Answer: Vivacitas is a private clinical-stage biopharmaceutical company focused on developing next-generation oncological therapies and re-designing current treatments that, even when efficacious, are overshadowed by their toxic effects on patients. Vivacitas lead compound, AR-67, is a Camptothecin-based technology that has already shown an attractive clinical profile in Phase I and II studies, wherein patients with solid tumors experienced less toxicity with a positive efficacy trend. Through an enduring spirit, Vivacitas continues to apply clarity, tenacity and vision in our fight against aggressive cancers and our pursuit of new treatment options for patients and their families worldwide.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access